DFTX FY 2017 Earnings — Definium Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

DFTXDefinium Therapeutics, Inc.

$2B

FY 2017 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$0

Gross Profit

-$5,500

Operating Income

-$1M

Net Income

-$1M

EPS (Diluted)

$-4.85

Cash Flow

Operating Cash Flow

-$665,984

Free Cash Flow

-$3M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$4M

Total Liabilities

$80,443

Stockholders' Equity

$4M

Cash & Equivalents

$3,977

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$5,500	$0	—
Operating Income	-$1M	-$111,250	-1010.2%
Net Income	-$1M	-$179,900	-581.9%